PULMONARY RESECTION FOR LUNG CANCER PATIENTS ON HEMODIALYSIS

PULMONARY RESECTION FOR LUNG CANCER PATIENTS ON HEMODIALYSIS

October 2008, Vol 134, No. 4_MeetingAbstracts Abstract: Poster Presentations | October 2008 PULMONARY RESECTION FOR LUNG CANCER PATIENTS ON HEMODIALY...

143KB Sizes 2 Downloads 106 Views

October 2008, Vol 134, No. 4_MeetingAbstracts Abstract: Poster Presentations | October 2008

PULMONARY RESECTION FOR LUNG CANCER PATIENTS ON HEMODIALYSIS Makoto Takahama, MD*; Ryoji Yamamoto, MD; Ryu Nakajima, MD; Hirohito Tada, MD Osaka City General Hosipital, Osaka, Japan Chest Chest. 2008;134(4_MeetingAbstracts):p77004. doi:10.1378/chest.134.4_MeetingAbstracts.p77004

Abstract PURPOSE: We retrospectively analyzed the clinical characteristics of the patients on hemodialysis who underwent pulmonary resection for lung cancers. METHODS: A total of 22 patients (mean age 65.6 years, ranged from 46 to 83) on hemodialysis underwent pulmonary resections at our institution from December 1994 to December 2007. The causes of hemodialysis were consisted of 12 patients on diabetes mellitus, 5 on chronic glomerulonephritis, 2 on nephrosclerosis and 5 on others. The mean levels of blood urea nitrogen and serum creatinine were 58.5mg/dL and 9.4 mg/dL, respectively. RESULTS: The histologic diagnoses were squamous cell carcinoma in 12 patients, adenocarcinoma in 7, small cell carcinoma in 2 and adenosquamous carcinoma in 1. Twenty patients underwent lobectomy, 1 underwent a wedge resection and 1 underwent a segmentectomy. There was no operative mortality. There were 7 cases of prolonged air leak, 3 cases of acute heart failure, 2 of sputum retention, and 1 of chylothorax. The disease free interval was 22.9+/−22.6 months, ranging from 2 to 85 months. CONCLUSION: In patients on hemodialysis who undergo pulmonary resection, there is a high incidence of pulmonary and cardiac complications. CLINICAL IMPLICATIONS: Careful postoperative management is mandatory during postoperative period. DISCLOSURE: Makoto Takahama, No Financial Disclosure Information; No Product/Research Disclosure Information Tuesday, October 28, 2008 1:00 PM - 2:15 PM